Siemens Healthineers is a German multinational medical technology company focused on diagnostic and therapeutic imaging, diagnostics, and related healthcare solutions. The company was founded in 2017 and is headquartered in Erlangen, Germany. Its shares are listed on the Frankfurt Stock Exchange under ticker SHL.
The AI-driven precision medicine market is projected to grow from $0.7 billion in 2025 to $9.7 billion by 2035 at a 26.8% CAGR. North America dominates with 62-67% market share, while machine learning accounts for 39% of the market. The market is moderately consolidated with the top five players controlling over 64% share.
Phase III trial of 196 patients shows stereotactic radiation targeting individual tumors significantly improved symptom burden and daily functioning compared with hippocampal-avoidance whole-brain radiation, without compromising survival.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07582744 |
CVFs in SIH: EID vs. PCD CTM |
NOT_YET_RECRUITING | NA |
| NCT04772157 |
Safe Emergency Department DIscharGE Rate (SEIGE) |
COMPLETED | |
| NCT04280926 |
Use of High Sensitivity Cardiac Troponin in Ruling Out Emergency Patients with Acute Myocardial Injury and Infarction |
COMPLETED |
